This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.
Stay at the RNA frontier with Hongene -- Cutting edge science, technology breakthroughs, and industry insights.
Mar 18, 2025David Butler, CTO
This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.